0.140
0.000
(0.00%)
As of 9:43:13 AM GMT+8. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
102,871
102,871
78,972
31,161
12,032
Cost of Revenue
38,707
38,707
30,078
12,385
5,154
Gross Profit
64,164
64,164
48,894
18,776
6,878
Operating Expense
429,278
429,278
498,409
673,518
237,971
Operating Income
-365,114
-365,114
-449,515
-654,742
-231,093
Net Non Operating Interest Income Expense
2,029
2,029
-2,970
-472
-2,909
Pretax Income
-378,837
-378,837
-483,475
-1,077,006
-846,043
Net Income Common Stockholders
-378,837
-378,837
-483,475
-1,077,006
-846,043
Diluted NI Available to Com Stockholders
-378,837
-378,837
-483,475
-1,077,006
-846,043
Basic EPS
-0.89
--
-1.14
-11.43
-1.99
Diluted EPS
-0.89
--
-1.14
-11.43
-1.99
Basic Average Shares
424,378.752
--
424,210.824
94,241.487
424,191.920
Diluted Average Shares
424,378.752
--
424,210.824
94,241.487
424,191.920
Total Expenses
467,985
467,985
528,487
685,903
243,125
Net Income from Continuing & Discontinued Operation
-378,837
-378,837
-483,475
-1,077,006
-846,043
Normalized Income
-379,075
-379,075
-483,910
-1,121,187
-825,297
Interest Income
10,977
10,977
3,893
2,607
964
Interest Expense
8,948
8,948
6,863
3,079
3,794
Net Interest Income
2,029
2,029
-2,970
-472
-2,909
EBIT
-369,889
-369,889
-476,612
-1,073,927
-842,249
EBITDA
-341,429
-341,429
-454,634
-1,058,221
-824,410
Reconciled Cost of Revenue
38,707
38,707
30,078
12,385
5,154
Reconciled Depreciation
28,460
28,460
21,978
15,706
17,839
Net Income from Continuing Operation Net Minority Interest
-378,837
-378,837
-483,475
-1,077,006
-846,043
Total Unusual Items Excluding Goodwill
238
238
435
44,181
-20,746
Total Unusual Items
238
238
435
44,181
-20,746
Normalized EBITDA
-341,667
-341,667
-455,069
-1,102,402
-803,664
12/31/2020 - 12/10/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2126.HK JW (Cayman) Therapeutics Co. Ltd
1.480
+3.50%
ESLA Estrella Immunopharma, Inc.
0.8880
+5.65%
IUGNF Imugene Limited
0.0250
0.00%
ADAG Adagene Inc.
1.4000
-3.45%
OCS Oculis Holding AG
16.24
+9.73%
NXTC NextCure, Inc.
0.2924
-10.00%
CRGX CARGO Therapeutics, Inc.
4.0500
+4.92%
1801.HK INNOVENT BIO
44.650
+5.81%
IPSC Century Therapeutics, Inc.
0.4185
+7.56%
LYEL Lyell Immunopharma, Inc.
0.4414
+6.85%